Nuclear Medicine: Extrathoracic Vascular Imaging

Published on 24/02/2015 by admin

Filed under Cardiovascular

Last modified 24/02/2015

Print this page

This article have been viewed 1200 times

CHAPTER 85 Nuclear Medicine

Extrathoracic Vascular Imaging

Amit Majmudar, James K. O’Donnell

Compared with catheter angiography, CT angiography, and MR angiography, nuclear medicine is a small component of extrathoracic vascular imaging. This component is crucial, however; the specific questions answered safely and efficiently by nuclear medicine cannot be answered by any other modality. Historically, radioisotope techniques have been used widely to answer research and clinical vascular questions. Some early nuclear angiographic procedures contributed greatly to our knowledge of cardiac and vascular physiology and diagnosis of various peripheral vascular disorders.¹ These techniques capitalize on the ability of noninvasive radioisotope imaging to depict existing physiologic parameters accurately without changing the physiology being interrogated.

Three specific studies occupy pivotal, indispensable roles in contemporary clinical algorithms: Tc 99m–radiolabeled erythrocyte scanning for acute gastrointestinal bleeding, Tc 99m pertechnetate imaging for the detection and management of Meckel diverticulum causing intermittent gastrointestinal bleeding, and brain perfusion tomographic single photon emission computed tomography (SPECT) imaging before and after administration of acetazolamide (Diamox) for the assessment of cerebrovascular reserve. Modern dynamic imaging techniques, image display, and improvements in erythrocyte labeling efficiency have optimized these studies. Reliable, definitive information is delivered to angiographers, neurointerventionalists, and surgeons to assist in patient management decisions.

Bleeding studies benefit from dynamic cine sequences, which show in rapid succession multiple images acquired at short intervals (Fig. 85-1). This sequence of images gives the interpreting physician greater confidence in localizing a bleeding site or visualizing the progressive accumulation of activity in a Meckel diverticulum (Fig. 85-2). Brain SPECT studies have benefited from advances in software allowing digital image fusion of the radioisotope study with CT or MRI anatomic sectional images, further computer comparison with probabilistic brain atlases, and three-dimensional volume rendering.

FIGURE 85-1 Dynamic images show intraluminal radiotracer originating at the hepatic flexure (first row, arrow) that progresses antegrade, crossing midline along the course of the transverse colon (second row, arrow). The upper left corner image is a single image from the dynamic cine presentation.

FIGURE 85-2 This static image shows abnormal accumulation of pertechnetate in the right lower quadrant (arrow), a common location for a Meckel diverticulum. The intense activity in the upper abdomen conforms to the stomach.

Nuclear medicine continues to refine its preexisting role in extrathoracic cardiac imaging even as it expands to assess atherosclerosis with positron emission tomography with ¹⁸FDG. This study is still in its experimental phase, but shows great promise as an imaging adjunct.²

TECHNICAL REQUIREMENTS

Gastrointestinal bleeding studies including Tc 99m–radiolabeled erythrocyte scans and Tc 99m pertechnetate scans require a standard gamma camera with a large field of view. A low-energy, high-resolution, parallel hole collimator should be used, and a 20% window should be centered at 140 keV. An identical energy window should be used for the acetazolamide brain perfusion SPECT scan, but the gamma camera must have its one or more detector heads mounted on a rotating gantry programmable to rotate in a 360-degree arc around the head of the patient.

GASTROINTESTINAL BLEED LOCALIZATION SCAN

Indications and Contraindications

A Tc 99m–radiolabeled erythrocyte scan should be performed to help localize the vascular origin of acute gastrointestinal bleeding involving the colon. The technique is less accurate in the assessment of upper gastrointestinal tract bleeding. The only major contraindication is a bleed so rapid that it is best spared scintigraphic interrogation in favor of immediate contrast angiography. The bleeding localization study may require too much radiolabeling preparation and imaging time to be performed on an acutely unstable patient.

Technique Description

No specific patient preparation is required for a Tc 99m–radiolabeled erythrocyte scan. This is an advantage because studies for gastrointestinal bleeding are usually requested emergently. Various labeling methods and kits are available to label the red blood cell, including an in vitro method, an in vivo method, and a hybrid method. The in vitro method using widely available kits typically provides very high labeling efficiency (e.g., Ultratag kit [Mallinckrodt, Inc., St. Louis]) provides a labeling efficiency of 98.5%).³ What the methods have in common is the use of stannous ion as a reducing agent and the Tc 99m label.

The patient is positioned supine with the camera located anteriorly. On initial intravenous injection of the radiolabeled erythrocytes, initial flow images are obtained at 1 s/frame for 60 frames. Subsequent dynamic images are obtained at 1 min/frame for 60 additional frames. A 128 × 128 image matrix is normally used for both acquisitions.⁴ Additional imaging may be repeated at intervals up to 24 hours, but all acquisitions should be in a dynamic series to enable detection of subtle bleeding sites and peristaltic transit through the bowel.

Pitfalls and Solutions

The most common technical pitfall of the Tc 99m–radiolabeled erythrocyte scan relates to an imperfect tagging of the blood cells, leaving free Tc 99m pertechnetate in the bloodstream. As described earlier, tagging efficiency is typically very high, especially with the in vitro technique. Common drugs such as heparin, penicillin, and iodinated contrast media interfere with the entry of the reducing agent (Sn⁺⁺) through the red blood cell membrane, however, causing an increased amount of free pertechnetate in the blood.⁵ Also, alternative in vivo labeling techniques may allow a certain amount of free pertechnetate to circulate.

Free pertechnetate appears in the stomach where it is physiologically secreted by the gastric parietal cells (see Fig. 85-2). This activity has an intraluminal configuration and moves antegrade over time. This movement can simulate an upper gastrointestinal bleed. In some instances, an upper gastrointestinal bleed may have been ruled out from a recent endoscopy, or the clinical presentation may not be consistent with one. A static image of the neck also reveals physiologic uptake of pertechnetate in the thyroid gland. After confirmation of the presence of free pertechnetate, the best solution is to allow for it in the interpretation. A brisk lower gastrointestinal bleed should be differentiated easily on dynamic imaging.

Another pitfall, related to the physiology of gastrointestinal bleeding itself, is intermittent bleeding. In Tc 99m sulfur colloid scanning (no longer commonly performed), after an initial 20-minute window, the study ceases to be diagnostic because of rapid radiopharmaceutical clearance by the liver. With Tc 99m–radiolabeled erythrocyte scans, however, delayed imaging up to 24 hours is possible. Delayed imaging can solve the problem of bleeding that has stopped temporarily during the initial imaging session.

Buy Membership for Cardiovascular Category to continue reading. Learn more here